Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02627963 |
|---|---|
| Brief Title: | A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) |
| First Submitted : | December 9, 2015 |
| First Submitted that Met QC Criteria : | December 10, 2015 |
| First Posted : | December 11, 2015 (Estimate) |
| Results First Submitted : | January 16, 2020 |
| Results First Submitted that Met QC Criteria : | February 10, 2020 |
| Results First Posted : | February 20, 2020 |
| Last Update Submitted that Met QC Criteria : | June 27, 2023 |
| Last Update Posted : | July 18, 2023 |